|
| |
Histiocytosis Non-Langerhans-CellDownload PDF containing detailed information.
Recent Publications on Histiocytosis Non-Langerhans-Cell: |  |
Cerebral non-Langerhans cell histiocytosis in a 17-year-old patient with a headache: case report.
A very rare inflammatory systemic rheumatic disorder--Multicentric... | 17th November, 2009
|
| J Neurol. 2009 Aug;256(8):1377-8. Epub 2009 Apr 12.
DOI Direct Link |
[Necrobiotic xanthogranuloma: efficacy of surgery in 2 patients]
Necrobiotic xanthogranuloma is a rare disease characterized by indurated... | 3rd October, 2009
| Servicio de Cirugia Plastica, Hospitales Universitarios Virgen del Rocio,
| Actas Dermosifiliogr. 2009 Jul-Aug;100(6):499-502.
|
An indolent and progressive papulonodular eruption.
Necrobiotic xanthogranuloma is a rare disease characterized by indurated... | 24th September, 2009
| Department of Dermatology, University of Puerto Rico, Puerto Rico.
| Int J Dermatol. 2009 Jul;48(7):751-2.
DOI Direct Link |
Multiple adult xanthogranuloma in intertriginous areas.
A very rare inflammatory systemic rheumatic disorder--Multicentric... | 21st August, 2009
|
| J Dermatol. 2009 Mar;36(3):176-8.
DOI Direct Link |
[Multicentric reticulohistiocytosis]
A very rare inflammatory systemic rheumatic disorder--Multicentric... | 6th August, 2009
| Klinika za bolesti srca i reumatizam, KCU Sarajevo, Bosna i Hercegovina.
| Med Arh. 2009;63(2):108-9.
|
→View more research publications. |
Press Releases About Histiocytosis Non-Langerhans-Cell:
|
 |
| Bioniche Strengthens the International Patent Portfolio for its MCC Technology Platform |
24th November, 2009 |
Bioniche Life Sciences Inc. |
-Japanese patent issuances facilitate commercialization of MCC in Japan-
BELLEVILLE, ON, Nov. 24 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven
|
| Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting |
24th November, 2009 |
Ambit Biosciences Corporation |
SAN DIEGO, Nov. 24 /PRNewswire/ -- Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the
|
| Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger |
24th November, 2009 |
Hard to Treat Diseases |
BELGRADE, Serbia, Nov. 24 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica Bio Chem, is providing this brief update to its
|
| Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference |
24th November, 2009 |
Cell Therapeutics, Inc. |
SEATTLE, Nov. 24 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the 21st Annual Piper Jaffray Health Care Conference. The conference will be
|
| Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group |
20th November, 2009 |
Cell Therapeutics, Inc. |
SEATTLE, Nov. 20 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled
|
BioPortfolio Ltd. offers e-mail and postal lists for Histiocytosis Non-Langerhans-Cell scientists - we have details of around 140 individuals working on Histiocytosis Non-Langerhans-Cell .
This page has been viewed 390 times
Recent Search Terms used to find this page: histiocytosis puerto rico | inflamatory histeocytosis | histiocytosis adult non-langerhans | histiocytosis adult non-langerhans | histiocitosis de no langerhans | non-langerhans cell histiocytosis | non langerhans histiocytosis | langerhans and non-langerhans histiocytosis | nonlangerhans histiocytosis | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Histiocytosis Non-Langerhans-Cell across BioPortfolio, or for Histiocytosis Non-Langerhans-Cell Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
